Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

CUSIP: 00461U105

Q1 2022 13F Holders as of 31 Mar 2022

Security identity
Security type / class
Equity / Common Stock, $0.00001 par value
Shares outstanding
138,752,791
Holder snapshot
Total 13F shares
59,295,213
Share change
+3,107,255
Total reported value
$1,021,908,185
Put/Call ratio
90%
Reported price per share
$17.24
Number of holders
107
Value change
+$59,352,437
Number of buys
44
Number of sells
71

Security key

00461U105

Report period

Q1 2022

Institutions

107

Top holders

10

ACRS full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2022 Previous quarter: Q4 2021 Aclaris Therapeutics, Inc. SEC filings Aclaris Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
WELLINGTON MANAGEMENT GRO...
13D/G signal
—
Evidence rows
15
Latest as of
31 Dec 2021
13F Lead comparable stake: 4% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
4%
$80,540,000
5,539,268 shares
 — 31 Dec 2021
Venrock Adviser, LLC
13F
Company
13F
3.3%
$66,360,000
4,563,962 shares
 — 31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
2.9%
$59,307,000
4,078,875 shares
 — 31 Dec 2021
Rock Springs Capital Management LP
13F
Company
13F
2.8%
$56,144,000
3,861,347 shares
 — 31 Dec 2021
Foresite Capital Management IV, LLC
13F
Company
13F
2.4%
$49,422,000
3,399,034 shares
 — 31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
2%
$39,522,000
2,718,107 shares
 — 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
107
Shares
59,295,213
Rows available
107
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
133
Q1 2022 holders
107
Holder diff
-26
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .